Clinical Trials Now Enrolling


Temsirolimus in Recurrent High-Grade Glioma

Learn More

Trial Eligibility

Status: Recruiting

Visit ClinicalTrials.gov or use NCT identifier NCT05773326 to view inclusion criteria and additional study details.

Trial Screening

SONODYNAMIC THERAPY IN RECURRENT GLIOBLASTOMA

Learn More

Trial Eligibility

Status: Recruiting

Visit ClinicalTrials.gov or use NCT identifier NCT05370508 to view inclusion criteria and additional study details.

Trial Screening

AZD1390 FOR RECURRENT GLIOBLASTOMA

Learn More

Trial Eligibility

Status: Recruiting

Visit ClinicalTrials.gov or use NCT identifier NCT05182905 to view inclusion criteria and additional study details.

Trial Screening

SONODYNAMIC THERAPY IN RECURRENT HIGH-GRADE GLIOMA

Learn More

Trial Eligibility

Status: Recruiting

Visit ClinicalTrials.gov or use NCT identifier NCT04559685 to view inclusion criteria and additional study details.

Trial Screening

NIRAPARIB FOR NEWLY DIAGNOSED GLIOBLASTOMA

Learn More

Trial Eligibility

Status: Recruiting

Visit ClinicalTrials.gov or use NCT identifier NCT05076513 to view inclusion criteria and additional study details.

Trial Screening

PAMIPARIB IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA

Learn More

Trial Eligibility

Status: Recruiting

Visit ClinicalTrials.gov or use NCT identifier NCT04614909 to view inclusion criteria and additional study details.

Trial Screening

ABEMACICLIB PLUS LY3214996 FOR RECURRENT GLIOBLASTOMA

Learn More

Trial Eligibility

Status: Recruiting

Visit ClinicalTrials.gov or use NCT identifier NCT04391595 to view inclusion criteria and additional study details.

Trial Screening Physician Information

INFIGRATINIB FOR RECURRENT HIGH-GRADE GLIOMA

Learn More

Trial Eligibility

Status: Active, not recruiting

Visit ClinicalTrials.gov or use NCT identifier NCT04424966 to view inclusion criteria and additional study details.

Physician Information

RIBOCICLIB FOR RECURRENT GLIOBLASTOMA


Trial Eligibility

Status: Active, not recruiting

Visit ClinicalTrials.gov or use NCT identifier NCT02933736  to view inclusion criteria and additional study details.


RIBOCICLIB FOR RECURRENT MENINGIOMA


Trial Eligibility

Status: Active, not recruiting

Visit ClinicalTrials.gov or use NCT identifier NCT02933736  to view inclusion criteria and additional study details.